Bipolar & Addiction

Understanding bipolar disorder: types, symptoms, and misdiagnosis

Bipolar disorder is a mood disorder characterized by dramatic shifts in mood, energy, and activity that cycle between distinct episodes rather than remaining in a stable baseline. The DSM-5 identifies several types. Bipolar I disorder is defined by the occurrence of at least one full manic episode lasting at least seven days (or any duration if hospitalization is required), in which mood is abnormally and persistently elevated, expansive, or irritable with increased goal-directed activity. Depressive episodes are common in Bipolar I but not required for diagnosis. Bipolar II disorder requires at least one hypomanic episode (a less severe manic state lasting at least four days, without hospitalization or psychotic features) and at least one major depressive episode.

Cyclothymic disorder involves numerous periods of hypomanic and depressive symptoms over at least two years that do not meet the full criteria for either. In all types, the disorder is lifelong, episodic, and highly manageable with appropriate treatment. Without treatment, episode frequency tends to increase over time through a process called kindling, where each episode makes the next more likely.

Bipolar disorder is frequently misdiagnosed as major depressive disorder, especially when clients first seek help during a depressive episode and manic or hypomanic history is not elicited carefully. Antidepressants prescribed without mood stabilizers in someone with unrecognized bipolar disorder can trigger hypomanic or manic episodes, which is why a thorough intake assessment, including a review of past mood elevation, sleep changes, and periods of unusual energy or impulsivity, is critical.

The connection between bipolar disorder and substance use

Bipolar disorder produces the neurobiological conditions that make substance use powerfully reinforcing. During depressive phases, alcohol and opioids provide relief from the hopelessness, fatigue, and anhedonia that define major depression. During manic or hypomanic phases, alcohol lowers social inhibition, cannabis amplifies the euphoria, and stimulants may feel congruent with the energized state. Impulsivity, a core feature of both manic and hypomanic episodes, makes it significantly harder to resist use.

Substance use in turn is one of the most reliable triggers for mood episodes. Alcohol and stimulants in particular destabilize the sleep-wake cycle that is one of the most important regulators of mood in bipolar disorder. Even one or two nights of sleep disruption can precipitate a manic episode in someone with bipolar disorder. Stimulants can push someone into full mania. Alcohol and opioids can deepen and prolong depressive episodes. Most critically, substance use interferes with the effectiveness of mood-stabilizing medications, making the entire pharmacological management of the illness less reliable.

SAMHSA's 2022 National Survey on Drug Use and Health identified an estimated 21.5 million U.S. adults with co-occurring mental illness and substance use disorder, with bipolar disorder representing one of the highest-comorbidity mental health diagnoses in that population. Understanding why this combination is so common is the first step toward effective integrated treatment.

Why integrated treatment is essential for bipolar disorder and addiction

Treating the addiction while leaving bipolar disorder unmanaged keeps mood instability as the primary driver of impulsive use, sabotages medication adherence, and makes the mood cycle unpredictable. Treating the bipolar disorder while substance use continues undermines the effectiveness of mood stabilizers, destabilizes sleep, and repeatedly triggers episodes. Sequential treatment for this combination, in either direction, has a poor evidence base.

NIMH and SAMHSA both identify integrated, simultaneous treatment as the clinical standard for co-occurring bipolar disorder and substance use. At The Archangel Centers, integration means the same psychiatrist who manages lithium, valproate, lamotrigine, or atypical antipsychotics is also overseeing the substance use disorder treatment, with full visibility into any MAT and the active therapeutic work in CBT. There are no competing instructions from two separate providers and no gaps between the mental health and addiction sides of care.

Our integrated approach also allows for more accurate medication management. Antidepressants, for example, must be used cautiously in bipolar disorder because they can induce manic episodes, particularly without an adequate mood stabilizer on board. When the full clinical picture is held by one team, these risks are managed proactively rather than discovered after an episode.

Clinical modalities used to treat bipolar disorder and addiction together

Bipolar disorder is a lifelong condition that is highly manageable with the right combination of medication, therapy, and structure. Our treatment approach addresses mood stabilization and addiction simultaneously.

• Psychiatric evaluation and medication management: on-site medical provider evaluates and manages mood stabilizers (lithium, valproate, lamotrigine), atypical antipsychotics, and MAT (Suboxone, Vivitrol, Sublocade), coordinating the full medication picture from one clinical vantage point
• Cognitive behavioral therapy (CBT) adapted for bipolar disorder: addresses the negative thought patterns and behavioral patterns associated with both depressive phases and the grandiosity and impulsivity of manic phases
• Dialectical behavior therapy (DBT): builds emotional regulation and distress tolerance skills specifically useful for the rapid emotional shifts of bipolar disorder, and reduces the impulsive decision-making that drives substance use
• Motivational interviewing: addresses ambivalence about medication adherence, one of the most common treatment challenges in bipolar disorder
• Sleep regularity protocols: structured intervention targeting the sleep-wake cycle, which is one of the most important episode triggers in bipolar disorder
• Hypomanic and manic warning sign identification: psychoeducation and self-monitoring skills that allow clients to recognize early episode signals before they escalate
• Family-focused psychoeducation: structured sessions for family members, available under signed release, building the family's capacity to recognize warning signs, support medication adherence, and respond to early episodes appropriately
• Trauma-informed care with EMDR: available when trauma history underlies or co-occurs with the bipolar and substance use presentation
• Safety planning: completed on admission day using the Columbia Suicide Severity Rating Scale; revisited throughout treatment, with particular attention during depressive phases

What treatment looks like across the three stages

On admission day, the clinical assessment battery includes ASAM criteria, LOCUS mental health acuity scoring, PHQ-9, GAD-7, Columbia Suicide Severity Rating Scale, biopsychosocial evaluation, and a detailed mood episode history review covering past manic, hypomanic, and depressive episodes, prior medication trials, and sleep pattern history. This is particularly important because accurate diagnosis of bipolar disorder, especially ruling out Bipolar II and cyclothymia, requires a thorough longitudinal mood history.

The skill-building phase addresses CBT for mood, DBT emotional regulation, sleep hygiene and regularity, motivational interviewing for medication adherence, and addiction relapse prevention. The medical provider monitors mood trajectory, sleep, and any ideation at regular intervals and adjusts the medication plan as needed. Medication adjustments in bipolar disorder, particularly titrating mood stabilizers and managing the interaction between MAT and psychiatric medications, require the kind of close, frequent monitoring that outpatient care at the Partial Care level is designed to provide.

As mood stabilizes and the substance use disorder is in remission, the focus shifts to applying skills in real environments, building a long-term mood management plan, and planning discharge that connects the client to outpatient continuing care, community support, and ongoing psychiatric medication management. Because bipolar disorder is a chronic condition, the relationship with our clinical team extends well beyond the intensive phases of treatment.

Levels of care: Partial Care, IOP, and outpatient

Acute mood instability paired with active substance use frequently warrants the clinical density of Partial Hospitalization (Partial Care), where daily structure and close psychiatric oversight allow medication to be titrated effectively while addiction treatment proceeds in parallel. Our Tinton Falls, New Jersey clinic runs Partial Care six days per week, Monday through Saturday. Our Charlotte, North Carolina clinic runs PHP five days per week, Monday through Friday. Both are full-day programs.

Intensive Outpatient, available at both locations on a schedule of three or five days per week for three-hour sessions, serves clients stepping down from Partial Care or those who present initially with moderate symptoms. Standard outpatient continuing care provides ongoing individual therapy, periodic psychiatric medication management, and group programming as needed. Because bipolar disorder requires ongoing medication management, the outpatient relationship continues indefinitely as a maintenance and monitoring partnership.

Virtual treatment is available to New Jersey residents. The Archangel Centers does not provide inpatient psychiatric care; when acute mania, psychosis, or safety concerns exceed outpatient scope, the team coordinates hospitalization and supports the transition back to outpatient programming when the client is stable.

Insurance, cost, and getting started

The Archangel Centers is in-network with Aetna, Cigna, BlueCross BlueShield, United Healthcare, Horizon BCBS, AmeriHealth NJ, Humana, and Tricare. Free insurance benefit verification is available before any commitment, typically within the first call, so out-of-pocket costs are transparent. Most major commercial plans cover medically necessary outpatient dual-diagnosis treatment under the Mental Health Parity and Addiction Equity Act. Sliding scale and payment plan options are available for clients with limited coverage.

Admissions is confidential, available 24 hours a day, seven days a week. Calling (888) 464-2144 connects you or a family member to a specialist who can verify benefits, discuss the right level of care, and often arrange same-week placement. No prior referral is required.